CLINICAL_TRIALS
trial_result
· 2025-08-29
Clinical Trial Update: A Study Evaluating the Safety and Tolerability of QRL-201 in ALS [Phase 1]
Summary
This Phase 1 trial assesses the safety and tolerability of QRL-201 in amyotrophic lateral sclerosis. It is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: QurAlis Corporation | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING